Intuitive Surgical Inc
NASDAQ:ISRG
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
309.52
550.62
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one ISRG stock under the Base Case scenario is 170.44 USD. Compared to the current market price of 547.87 USD, Intuitive Surgical Inc is Overvalued by 69%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Intuitive Surgical Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for ISRG cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Intuitive Surgical Inc
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Intuitive Surgical Inc. is a pioneering force in the medical technology landscape, best known for its groundbreaking da Vinci Surgical System. Founded in 1995 and headquartered in Sunnyvale, California, the company has transformed minimally invasive surgery, enabling surgeons to perform complex procedures with unparalleled precision and control. Using robotic-assisted technology, Intuitive Surgical provides tools that enhance surgical outcomes and patient recovery. This focus on innovation has solidified the company's reputation as a leader in the healthcare sector, particularly in areas such as urology, gynecology, and general surgery, where demand for minimally invasive procedures continue...
Intuitive Surgical Inc. is a pioneering force in the medical technology landscape, best known for its groundbreaking da Vinci Surgical System. Founded in 1995 and headquartered in Sunnyvale, California, the company has transformed minimally invasive surgery, enabling surgeons to perform complex procedures with unparalleled precision and control. Using robotic-assisted technology, Intuitive Surgical provides tools that enhance surgical outcomes and patient recovery. This focus on innovation has solidified the company's reputation as a leader in the healthcare sector, particularly in areas such as urology, gynecology, and general surgery, where demand for minimally invasive procedures continues to rise.
For investors, Intuitive Surgical represents a compelling opportunity due to its consistent revenue growth and strong profit margins. The company's business model relies on recurring revenue from both the sale of surgical systems and the instruments and accessories required for surgeries, creating a robust stream of cash flow. With a growing installed base of surgical systems and increasing global procedure volumes, Intuitive is well-positioned to benefit from the rising trend toward advanced surgical techniques. Moreover, the company commits significant resources to research and development, ensuring it remains at the forefront of medical innovation. As healthcare evolves and the need for improved surgical outcomes intensifies, Intuitive Surgical stands as a beacon of potential for those looking to invest in the future of medicine.
Intuitive Surgical Inc. is primarily known for its innovative robotic surgical systems, particularly the da Vinci Surgical System. The company operates through several core business segments:
-
Robotic Surgical Systems: This is the flagship segment of Intuitive Surgical. The da Vinci Surgical System allows surgeons to perform minimally invasive surgeries with precision and control. This segment includes the sales of new surgical systems, upgrades, and accessories.
-
Instruments and Accessories: This segment involves the sale of surgical instruments and accessories used in conjunction with the da Vinci system. These are often disposable items that need to be replenished after surgeries, providing a recurring revenue stream for the company.
-
Services and Maintenance: Intuitive Surgical offers services that include installation, servicing, and maintenance of its robotic surgical systems. This segment ensures that the systems are functional and up-to-date, contributing to customer satisfaction and long-term relationships.
-
Training and Education: This segment provides training for surgeons and medical staff on how to effectively operate the da Vinci systems. Robust training programs ensure high proficiency and safety in robotic surgeries, which can improve patient outcomes and enhance the adoption of Intuitive's technology.
-
Research and Development (R&D): Although not a revenue-generating segment, R&D is crucial for Intuitive Surgical. This segment focuses on innovation and the development of next-generation surgical systems, instruments, and technologies, allowing the company to maintain its competitive edge and expand into new procedural areas.
Overall, Intuitive Surgical’s business model relies on a combination of system sales, recurring revenue through instruments and accessories, and a commitment to ongoing support and development in the surgical robotics field.
Intuitive Surgical Inc., best known for its da Vinci Surgical System, has several unique competitive advantages that position it favorably within the surgical robotics market:
-
First-Mover Advantage: Intuitive Surgical was among the first companies to introduce robotic-assisted surgery. This early entry has allowed it to establish a strong brand reputation and a loyal customer base.
-
Brand Recognition: The da Vinci system is synonymous with robotic surgery, giving Intuitive Surgical a strong brand presence and trust among healthcare professionals and institutions.
-
Extensive Clinical Data: Intuitive has accumulated a wealth of clinical data supporting the efficacy and safety of its systems. This data helps convince hospitals and surgeons to adopt its technology over competitors.
-
Comprehensive Training Programs: Intuitive Surgical offers extensive training and support for surgeons and medical staff, ensuring they are well-prepared to use the da Vinci system effectively. This creates a more favorable experience for healthcare providers using their technology.
-
Robust Intellectual Property: The company holds numerous patents related to its technologies, which not only protects its innovations but also makes it harder for competitors to enter the market with similar offerings.
-
Strong Ecosystem: Intuitive Surgical has developed a comprehensive ecosystem, including surgical instruments, accessories, and software that enhance the capabilities of the da Vinci system. This integrated approach ensures that users have everything they need within the Intuitive Surgical product family.
-
Ongoing Innovation: The company continually invests in research and development, improving existing products and creating new ones, which keeps it ahead of competitors in technology and performance.
-
Global Reach and Market Penetration: Intuitive Surgical has a significant presence in international markets, allowing it to capitalize on global demand for robotic-assisted surgeries.
-
Long-term Relationships with Hospitals: The company has established long-term agreements and partnerships with hospitals, creating a stable recurring revenue stream through instrument and accessory sales, along with service contracts.
-
Focus on Multispecialty Applications: While many competitors may focus on niche products, Intuitive offers its robotic systems across a variety of surgical applications (urology, gynecology, general surgery, etc.), expanding its market potential.
These competitive advantages enable Intuitive Surgical Inc. to sustain its market leadership and continue growing in the surgical robotics space.
Intuitive Surgical Inc., known for its da Vinci surgical systems, may face several risks and challenges in the near future, including:
-
Regulatory Hurdles: The company operates in a highly regulated environment. Regulatory approvals for new products or updates can be time-consuming and costly. Stricter regulations or changes in health policies could impact their operations.
-
Market Competition: The robotic surgical market is growing, attracting new competitors. Other companies are developing similar technologies that could compete with Intuitive Surgical’s existing products, potentially leading to price pressures.
-
Reimbursement Landscape: Changes in healthcare reimbursement policies can affect the demand for robotic surgery. If insurers reduce coverage or reimbursement rates for procedures performed using Intuitive's systems, it could lead to decreased sales.
-
Technological Advancements: Rapid advancements in medical technology could outpace Intuitive Surgical's innovations. If competitors bring more advanced or cost-effective solutions to market faster, Intuitive's market position could be threatened.
-
Dependence on Key Products: The company derives a significant portion of its revenue from its da Vinci systems. Any decline in demand, whether due to market saturation or the advent of alternatives, could materially affect the business.
-
Supply Chain Disruptions: Global supply chain issues, which have been exacerbated by events like the COVID-19 pandemic, can impact the production and distribution of their robotic systems and surgical instruments.
-
Litigation Risks: Intuitive Surgical faces potential legal challenges, including product liability lawsuits. Any adverse outcomes could lead to significant financial liabilities and reputational damage.
-
Economic Conditions: Economic downturns can impact hospital budgets and spending on capital equipment. Reduced capital expenditures in healthcare can affect the sales of surgical systems.
-
Cybersecurity Threats: As their systems become more interconnected and rely on software for operations, they may be vulnerable to cybersecurity attacks that could compromise patient data or lead to operational disruptions.
-
Training and Adoption Issues: Successfully integrating robotic surgical systems into hospital settings requires significant training for surgeons and staff. If hospitals are reluctant to adopt or invest in this training, Intuitive may see slower sales growth.
In summary, while Intuitive Surgical has a leading position in the robotics surgery market, it must navigate various internal and external challenges to maintain its growth and market share. Continuous innovation and strategic management will be essential for mitigating these risks.
Revenue & Expenses Breakdown
Intuitive Surgical Inc
Balance Sheet Decomposition
Intuitive Surgical Inc
Current Assets | 7.2B |
Cash & Short-Term Investments | 4.4B |
Receivables | 1.2B |
Other Current Assets | 1.7B |
Non-Current Assets | 10.5B |
Long-Term Investments | 4.1B |
PP&E | 4.4B |
Intangibles | 373.6m |
Other Non-Current Assets | 1.6B |
Current Liabilities | 1.7B |
Accounts Payable | 218.7m |
Accrued Liabilities | 867.5m |
Other Current Liabilities | 590.6m |
Non-Current Liabilities | 483.3m |
Other Non-Current Liabilities | 483.3m |
Earnings Waterfall
Intuitive Surgical Inc
Revenue
|
7.9B
USD
|
Cost of Revenue
|
-2.6B
USD
|
Gross Profit
|
5.3B
USD
|
Operating Expenses
|
-3.2B
USD
|
Operating Income
|
2.1B
USD
|
Other Expenses
|
174.7m
USD
|
Net Income
|
2.2B
USD
|
Free Cash Flow Analysis
Intuitive Surgical Inc
USD | |
Free Cash Flow | USD |
In Q3 2024, Intuitive recorded a 17% revenue growth to $2 billion, bolstered by an 18% rise in da Vinci procedures. The company anticipates a procedure growth range of 16-17% for the full year, raising its guidance's lower bound. Gross margins are projected between 68.5% and 69%. With the rollout of the da Vinci 5 system, placements increased significantly, while policies in Asia pose challenges. Capital expenditures are estimated at $1-1.2 billion, focused on facility construction. Operating expenses are now expected to grow 10-12%, a slight decrease from previous forecasts【4:9†source】.
What is Earnings Call?
ISRG Profitability Score
Profitability Due Diligence
Intuitive Surgical Inc's profitability score is 65/100. The higher the profitability score, the more profitable the company is.
Score
Intuitive Surgical Inc's profitability score is 65/100. The higher the profitability score, the more profitable the company is.
ISRG Solvency Score
Solvency Due Diligence
Intuitive Surgical Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
Intuitive Surgical Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ISRG Price Targets Summary
Intuitive Surgical Inc
According to Wall Street analysts, the average 1-year price target for ISRG is 554.22 USD with a low forecast of 447.43 USD and a high forecast of 675.15 USD.
Dividends
Current shareholder yield for ISRG is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
ISRG Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. The company is headquartered in Sunnyvale, California and currently employs 9,793 full-time employees. The company went IPO on 2000-06-13. The firm's products and related services enable physicians and healthcare providers to access minimally invasive care. The systems consist of a surgeon console or consoles, a patient-side cart, a vision system, and proprietary instruments and accessories. Its da Vinci products consist of five categories, such as da Vinci surgical systems, da Vinci instruments and accessories, da Vinci Stapling, da Vinci Energy, and da Vinci Vision, including Firefly Fluorescence imaging systems and da Vinci Endoscopes. The company also provides a suite of systems, learning, and services offerings. Its Ion endoluminal system extends its commercial offerings beyond surgery into diagnostic procedures, enabling minimally invasive biopsies in the lung. Its services include readiness support, maintenance support, OR consulting, customer hospital analytics, and market consulting optimization.
Contact
IPO
Employees
Officers
The intrinsic value of one ISRG stock under the Base Case scenario is 170.44 USD.
Compared to the current market price of 547.87 USD, Intuitive Surgical Inc is Overvalued by 69%.